Wellmune Linked to Fewer Cold-Flu Symptoms in Study
The ingredient reduced cold and flu symptoms by 43 days compared to placebo.
Wellmune WGP, a yeast beta-glucan ingredient from Biothera (Eagan, MN), has impressed in a new study on medical students during cold-flu season. The ingredient reduced cold and flu symptoms by 43 days compared to placebo. Results are now published in the June issue of the journal Nutrition.
Researchers at Southampton University Medical School assigned 100 healthy med students to 90 days of Wellmune WGP (250 mg daily) or placebo. Over the course of the study, 24 cases of upper respiratory tract infection were confirmed by medical staff-12 in each test group-but the Wellmune WGP group experienced fewer days with actual symptoms.
“The results are consistent with eight other clinical studies regarding the immune support effects of Wellmune WGP,” says Don Cox, PhD, senior vice president of research and development at Biothera.
The yeast beta-glucan is currently a focus of the EU’s FibeBiotics immune health project.
A country-by-country blueprint for nutraceutical success in Europe
May 20th 2025The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.
Polyphenols: The next generation of prebiotics is ready for liftoff
April 21st 2025Explore the prebiotic health benefits of polyphenols and the positive impact they may have on digestive and immune health. Polyphenols, such as those found in European black elderberry, may be an ideal solution for manufacturers trying to break into the digestive health space.
